Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Primary care for type 2 diabetes].

Anat Tsur, Ilana Harman-Boehm, Julio Wainstein

    Harefuah
    |June 12, 2004
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants.

    Nature medicine·2026
    Same author

    Inflammation in Target Organs: From the Bench to the Clinic.

    Cells·2026
    Same author

    Diabetes mellitus and diabetes-related complications are common in patients with myelodysplastic syndromes but Hemoglobin A1C is an inadequate marker.

    Haematologica·2026
    Same author

    Incentives and Equity: A Randomized Controlled Trial to Improve Glycemic Control in Socioeconomically Disadvantaged Patients With Diabetes.

    Annals of family medicine·2026
    Same author

    Glycaemic, appetite and circadian benefits of a dairy-enriched diet with high-protein breakfast and early daytime-restricted carbohydrate intake in type 2 diabetes: a randomised crossover trial.

    Diabetologia·2026
    Same author

    Risk of recurrent diabetic ketoacidosis following initiation of sodium-glucose co-transporter 2 inhibitors in patients with an insulin-deficient diabetes and prior diabetic ketoacidosis: An observational cohort study.

    Diabetes, obesity & metabolism·2026

    Type 2 diabetes is a growing global epidemic. A nationwide program optimizing metabolic control through primary care and specialized diabetes centers is crucial for effective treatment and complication prevention.

    Area of Science:

    • Endocrinology
    • Public Health
    • Healthcare Management

    Background:

    • Type 2 diabetes prevalence is escalating globally, projected to double in 25 years, posing significant healthcare costs.
    • Current primary care systems require enhanced support to manage the increasing burden of diabetes effectively.

    Discussion:

    • A nationwide program is proposed to optimize metabolic control and improve surveillance for type 2 diabetes.
    • Specialized diabetes centers should support primary care by managing complex cases and educating multidisciplinary teams.
    • Developing a local shared care framework between diabetes centers and primary care is essential for optimal patient outcomes.

    Key Insights:

    • Multidisciplinary teams from specialized diabetes centers are vital for reinforcing primary care knowledge and skills.

    Related Experiment Videos

  • Shared care models facilitate the achievement of treatment targets and prevention of diabetes complications.
  • Empowering primary care teams through specialized support is key to managing the diabetes epidemic.

    • Outlook:

    • Implementation of a coordinated, nationwide approach integrating primary and specialized care is recommended.
    • This integrated model aims to improve metabolic control, reduce healthcare expenditures, and prevent long-term diabetes complications.
    • Future efforts should focus on establishing robust shared care frameworks to combat the rising tide of type 2 diabetes.